Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glicost M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Aronex Life Sciences Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glicost M 1mg/500mg Tablet

DiabetaComb 1mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Always take DiabetaComb 1mg/500mg with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with well-controlled blood sugar, as discontinuation without medical guidance can elevate glucose levels, risking complications like kidney impairment, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Learn to recognize and manage these symptoms. Maintain regular meals and carry a readily available fast-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Inform your doctor of any history of heart conditions before commencing treatment; it may be unsuitable. Pregnant or lactating women should seek medical counsel prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Uses of Glicost M 1mg/500mg Tablet

Managing Type 2 Diabetes

Major Benefits of Glicost M 1mg/500mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or breaking it. Consume Glicost M 1mg/500mg tablets with a meal.

Common Side effects of Glicost M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glicost M 1mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glicost M 1mg/500mg tablets should be administered with a meal.

How Glicost M 1mg/500mg Tablet works:

Glicost M, a 1mg/500mg tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glicost M 1mg/500mg tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glicost M 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible hazards prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Glicost M 1mg/500mg tablets. Evidence indicates potential harm to the infant from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glicost M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glicost M 1mg/500mg tablets. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glicost M 1mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation with a low dose is typical; however, the medication is unsuitable for patients exhibiting severe hepatic dysfunction.

What if you forget to take Glicost M 1mg/500mg Tablet :

Should you forget a Glicost M 1mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glicost M 1mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glicost M 1mg/500mg Tablet

Maintain this medication within its original, securely sealed container. Follow the storage guidelines specified on the packaging. Discard any remaining medication. Prevent access by children, pets, and others.
Glicost M 1mg/500mg Tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more likely in individuals with kidney impairment, the elderly, or those who consume significant amounts of alcohol. Symptoms may involve muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or bradycardia. Should any of these symptoms appear, discontinue Glicost M 1mg/500mg Tablet use and seek immediate medical attention.
Glimepiride and Metformin, combined as Glicost M 1mg/500mg Tablet, manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood glucose control when coupled with a healthy diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, reducing blood glucose. Metformin decreases hepatic glucose production and improves insulin responsiveness. This formulation is unsuitable for treating type 1 DM.
Glicost M 1mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse events such as lactic acidosis are also possible. Prolonged treatment may result in vitamin B12 deficiency.
Indeed, prolonged Glicost M 1mg/500mg Tablet consumption can lead to Vitamin B12 deficiency by hindering its gastrointestinal absorption. This deficiency, if left unaddressed, may result in anemia, neurological complications such as paresthesia in the extremities, muscular weakness, urinary dysfunction, cognitive impairment, and gait instability. Preventive measures suggested by some studies involve supplemental Vitamin B12 intake at least annually.
Glicost M 1mg/500mg Tablets can induce hypoglycemia (low blood glucose). Manifestations of low blood sugar include nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carry a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glicost M 1mg/500mg tablets and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and heighten the risk of lactic acidosis.
Glicost M 1mg/500mg Table...
34
MRP 42
19% off